These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38305669)

  • 1. Review document of the Spanish Association of Neurogastroenterology and Motility on the management of opioid-induced constipation.
    Serra J; Alcedo J; Barber C; Ciriza de Los Ríos C
    Rev Esp Enferm Dig; 2024 Oct; 116(10):546-553. PubMed ID: 38305669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating naloxegol for the treatment of opioid-induced constipation.
    Daniali M; Nikfar S; Abdollahi M
    Expert Opin Pharmacother; 2020 Jun; 21(8):883-891. PubMed ID: 32129103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological prevention and treatment of opioid-induced constipation in cancer patients: A systematic review and meta-analysis.
    Kistemaker KRJ; Sijani F; Brinkman DJ; de Graeff A; Burchell GL; Steegers MAH; van Zuylen L
    Cancer Treat Rev; 2024 Apr; 125():102704. PubMed ID: 38452708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Use of Peripheral μ-Opioid Receptor Antagonists (PAMORA) in the Management of Opioid-Induced Constipation: An Update on Their Efficacy and Safety.
    Pergolizzi JV; Christo PJ; LeQuang JA; Magnusson P
    Drug Des Devel Ther; 2020; 14():1009-1025. PubMed ID: 32210534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights on efficacious doses of PAMORAs for patients on chronic opioid therapy or opioid-naïve patients.
    van Malderen K; Halawi H; Camilleri M
    Neurogastroenterol Motil; 2018 May; 30(5):e13250. PubMed ID: 29119706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid-induced constipation in chronic noncancer pain.
    Weber HC
    Curr Opin Endocrinol Diabetes Obes; 2016 Feb; 23(1):11-7. PubMed ID: 26702846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naloxegol: the first orally administered, peripherally acting, mu opioid receptor antagonist, approved for the treatment of opioid-induced constipation.
    Corsetti M; Tack J
    Drugs Today (Barc); 2015 Aug; 51(8):479-89. PubMed ID: 26380386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of Opioid-Induced Constipation and Bowel Dysfunction: Expert Opinion of an Italian Multidisciplinary Panel.
    De Giorgio R; Zucco FM; Chiarioni G; Mercadante S; Corazziari ES; Caraceni A; Odetti P; Giusti R; Marinangeli F; Pinto C
    Adv Ther; 2021 Jul; 38(7):3589-3621. PubMed ID: 34086265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Management of opioid-induced constipation : the old and the new].
    Arm J; Coen M; Pautex S; Nendaz M
    Rev Med Suisse; 2024 Oct; 20(892):1919-1925. PubMed ID: 39445365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of opioid-induced constipation: focus on the peripheral μ-opioid receptor antagonist methylnaltrexone.
    Rauck RL
    Drugs; 2013 Aug; 73(12):1297-306. PubMed ID: 23881667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of opioid-induced constipation in pregnancy: a concise review with emphasis on the PAMORAs.
    Li Z; Pergolizzi JV; Huttner RP; Zampogna G; Breve F; Raffa RB
    J Clin Pharm Ther; 2015 Dec; 40(6):615-9. PubMed ID: 26573866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-analgesic effects of opioids: management of opioid-induced constipation by peripheral opioid receptor antagonists: prevention or withdrawal?
    Holzer P
    Curr Pharm Des; 2012; 18(37):6010-20. PubMed ID: 22747544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treating Opioid-Induced Constipation in Older Adults: New Options.
    Sani H; Mahan RJ
    Consult Pharm; 2015 Oct; 30(10):612-5. PubMed ID: 26450143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripherally Acting μ-Opioid Receptor Antagonists for the Treatment of Opioid-Related Side Effects: Mechanism of Action and Clinical Implications.
    Streicher JM; Bilsky EJ
    J Pharm Pract; 2018 Dec; 31(6):658-669. PubMed ID: 28946783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Opioid-Induced Constipation in Patients with Cancer Pain].
    Aruga E
    Gan To Kagaku Ryoho; 2021 Nov; 48(11):1311-1315. PubMed ID: 34795117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naloxegol: A Novel Therapy in the Management of Opioid-Induced Constipation.
    Jones R; Prommer E; Backstedt D
    Am J Hosp Palliat Care; 2016 Nov; 33(9):875-880. PubMed ID: 26150678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging therapies for opioid-induced constipation: what can we expect?
    Roostaei G; Khoshnam Rad N; Fakhri B MS; Nikfar S; Abdollahi M
    Expert Opin Pharmacother; 2024 Sep; 25(13):1729-1738. PubMed ID: 39308446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Treatments for Opioid-Induced Constipation: Systematic Review and Meta-analysis.
    Nee J; Zakari M; Sugarman MA; Whelan J; Hirsch W; Sultan S; Ballou S; Iturrino J; Lembo A
    Clin Gastroenterol Hepatol; 2018 Oct; 16(10):1569-1584.e2. PubMed ID: 29374616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular Safety of the Selective μ-Opioid Receptor Antagonist Naloxegol: A Novel Therapy for Opioid-Induced Constipation.
    White WB; Kowey P; Diva U; Sostek M; Tummala R
    J Cardiovasc Pharmacol Ther; 2018 Jul; 23(4):309-317. PubMed ID: 29504415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving the recognition and diagnosis of opioid-induced constipation in clinical practice.
    Gupta A
    J Fam Pract; 2015 Oct; 64(10 Suppl 1):. PubMed ID: 26561554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.